STEM CELL RES THER 润色咨询

Stem Cell Research & Therapy

出版年份:2010 年文章数:2925 投稿命中率: 开通期刊会员,数据随心看

出版周期:Irregular 自引率:6.8% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2316536, encodeId=3b30231653687, content=260409完成技术审查之后就一直显示with editor阶段,到260516实在是有点着急,发邮件询问进度,那边回复邮件说在安排编辑审核(对,还没安排到编辑),现在0526,还是with editor,同组同时投的一篇一区已经大修了,只能说太慢太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93f69083252, createdName=ms3000000377448113, createdTime=Tue May 26 11:00:22 CST 2026, time=2026-05-26, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2308695, encodeId=afcc23086957a, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:真的好慢啊,2月份投的,4月中旬提交checklist,现在还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30f09061934, createdName=ms2000000030700368, createdTime=Thu Apr 23 12:50:59 CST 2026, time=2026-04-23, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2252763, encodeId=bd7a2252e635a, content=1月4号投了个综述,1月17号安排编辑,现在2月17还在编辑手里没送出去外审,这也太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73df6541609, createdName=ms1000000560525324, createdTime=Thu Feb 20 10:18:32 CST 2025, time=2025-02-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2320978, encodeId=21ec23209e88b, content=这个杂志外审这么快么,邀了4个专家,有两个专家三四天就返回意见了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30f09061934, createdName=ms2000000030700368, createdTime=Wed Jun 03 14:12:06 CST 2026, time=2026-06-03, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=964224, encodeId=d19f96422486, content=偏重的研究方向: 外泌体 ; 干细胞治疗 ; Tissue regeneration <br>经验分享:刚接收了一篇,出乎意料的快和顺利,一审20天,二审30天,两个月就接收了,感觉这个杂志比较好中,前面cell stem cell,stem cell reports,stem cells和ebiomedicine都是秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Mon May 10 10:00:20 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2256903, encodeId=35b02256903a9, content=偏重的研究方向:诱导多能干细胞;干细胞<br>经验分享:3.4投稿,3.6退回修改伦理,3.7重新提交,3.10 editor assigned到现在没变,太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e93b9459971, createdName=ms7000000466366687, createdTime=Thu Mar 20 14:31:48 CST 2025, time=2025-03-20, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1230958, encodeId=01841230958cd, content=更新一下情况,Springer Nature工作人员回复了,1 他们认为杂志的流程是有问题的,就是官网说的和实际的不是一回事,需要整改 2 他们很在意这个平等问题,我们的推测是对的,这漫长审稿流程只针对老中 3 他们说,据他们调查结果,所有稿件都要数据审查,但是我表示怀疑,有些稿件不到十天就在线发表,不知道他们的审查为什么如此高速,我的伦理只有一张纸就审查了一周多,而且还是在我不断催促的情况下。4 他很感谢我提出的问题,不然这些问题不会被曝光,会监控这个杂志。我会继续反映情况,因为那个publishing editor 还要继续搞我。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efd66150329, createdName=ms3000000510280882, createdTime=Wed Jul 06 18:06:24 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2264571, encodeId=d71a22645e16d, content=偏重的研究方向:干细胞治疗<br>经验分享:1.25投稿,没多久让澄清术语,刚好过年,差点错过提交时间,后来又返回让改格式,正式投2.10,很快送外审,当时还很高兴,没多久就变成reviewer assigned,然后到三月底还没有变,发邮件催,回复让推荐审稿人,回复过去一周还是没有更新状态,于是发邮件告知要撤稿,立刻变成under review,4.27外审回来,要求10天内修回,现在又是editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bf55176474, createdName=146e9a12m86暂无昵称, createdTime=Mon May 12 02:24:18 CST 2025, time=2025-05-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2257988, encodeId=0446225e98868, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:干细胞;肝纤维化<br>经验分享:一审10天完成,给了大修,2.25返修,3.1under review至今,希望二审审稿人手下留情啊啊啊啊,我等着急用。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60252134772, createdName=fyx000, createdTime=Thu Mar 27 15:17:48 CST 2025, time=2025-03-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2240797, encodeId=75dc2240e97a4, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:肺纤维化;间充质干细胞<br>经验分享:3.19一投,4.7号checklist, 8月4号给回两个评审意见minor review, 8月13号返回,8月26显示review completed,后来又变成under review到9.23,又给了一个reviewer的意见,9.26修回。到10.22号又给了一个reviewer的minor review,10.22当天修回,11月26初步接收,补充带marker的原始图,12月3号正式接收。一共8个月15天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2919515599, createdName=ms5000000432764812, createdTime=Wed Dec 04 17:43:05 CST 2024, time=2024-12-04, status=1, ipAttribution=北京)]
    2026-05-26 ms3000000377448113 来自天津

    260409完成技术审查之后就一直显示with editor阶段,到260516实在是有点着急,发邮件询问进度,那边回复邮件说在安排编辑审核(对,还没安排到编辑),现在0526,还是with editor,同组同时投的一篇一区已经大修了,只能说太慢太慢了

    6

    展开6条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2316536, encodeId=3b30231653687, content=260409完成技术审查之后就一直显示with editor阶段,到260516实在是有点着急,发邮件询问进度,那边回复邮件说在安排编辑审核(对,还没安排到编辑),现在0526,还是with editor,同组同时投的一篇一区已经大修了,只能说太慢太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93f69083252, createdName=ms3000000377448113, createdTime=Tue May 26 11:00:22 CST 2026, time=2026-05-26, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2308695, encodeId=afcc23086957a, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:真的好慢啊,2月份投的,4月中旬提交checklist,现在还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30f09061934, createdName=ms2000000030700368, createdTime=Thu Apr 23 12:50:59 CST 2026, time=2026-04-23, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2252763, encodeId=bd7a2252e635a, content=1月4号投了个综述,1月17号安排编辑,现在2月17还在编辑手里没送出去外审,这也太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73df6541609, createdName=ms1000000560525324, createdTime=Thu Feb 20 10:18:32 CST 2025, time=2025-02-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2320978, encodeId=21ec23209e88b, content=这个杂志外审这么快么,邀了4个专家,有两个专家三四天就返回意见了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30f09061934, createdName=ms2000000030700368, createdTime=Wed Jun 03 14:12:06 CST 2026, time=2026-06-03, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=964224, encodeId=d19f96422486, content=偏重的研究方向: 外泌体 ; 干细胞治疗 ; Tissue regeneration <br>经验分享:刚接收了一篇,出乎意料的快和顺利,一审20天,二审30天,两个月就接收了,感觉这个杂志比较好中,前面cell stem cell,stem cell reports,stem cells和ebiomedicine都是秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Mon May 10 10:00:20 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2256903, encodeId=35b02256903a9, content=偏重的研究方向:诱导多能干细胞;干细胞<br>经验分享:3.4投稿,3.6退回修改伦理,3.7重新提交,3.10 editor assigned到现在没变,太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e93b9459971, createdName=ms7000000466366687, createdTime=Thu Mar 20 14:31:48 CST 2025, time=2025-03-20, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1230958, encodeId=01841230958cd, content=更新一下情况,Springer Nature工作人员回复了,1 他们认为杂志的流程是有问题的,就是官网说的和实际的不是一回事,需要整改 2 他们很在意这个平等问题,我们的推测是对的,这漫长审稿流程只针对老中 3 他们说,据他们调查结果,所有稿件都要数据审查,但是我表示怀疑,有些稿件不到十天就在线发表,不知道他们的审查为什么如此高速,我的伦理只有一张纸就审查了一周多,而且还是在我不断催促的情况下。4 他很感谢我提出的问题,不然这些问题不会被曝光,会监控这个杂志。我会继续反映情况,因为那个publishing editor 还要继续搞我。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efd66150329, createdName=ms3000000510280882, createdTime=Wed Jul 06 18:06:24 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2264571, encodeId=d71a22645e16d, content=偏重的研究方向:干细胞治疗<br>经验分享:1.25投稿,没多久让澄清术语,刚好过年,差点错过提交时间,后来又返回让改格式,正式投2.10,很快送外审,当时还很高兴,没多久就变成reviewer assigned,然后到三月底还没有变,发邮件催,回复让推荐审稿人,回复过去一周还是没有更新状态,于是发邮件告知要撤稿,立刻变成under review,4.27外审回来,要求10天内修回,现在又是editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bf55176474, createdName=146e9a12m86暂无昵称, createdTime=Mon May 12 02:24:18 CST 2025, time=2025-05-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2257988, encodeId=0446225e98868, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:干细胞;肝纤维化<br>经验分享:一审10天完成,给了大修,2.25返修,3.1under review至今,希望二审审稿人手下留情啊啊啊啊,我等着急用。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60252134772, createdName=fyx000, createdTime=Thu Mar 27 15:17:48 CST 2025, time=2025-03-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2240797, encodeId=75dc2240e97a4, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:肺纤维化;间充质干细胞<br>经验分享:3.19一投,4.7号checklist, 8月4号给回两个评审意见minor review, 8月13号返回,8月26显示review completed,后来又变成under review到9.23,又给了一个reviewer的意见,9.26修回。到10.22号又给了一个reviewer的minor review,10.22当天修回,11月26初步接收,补充带marker的原始图,12月3号正式接收。一共8个月15天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2919515599, createdName=ms5000000432764812, createdTime=Wed Dec 04 17:43:05 CST 2024, time=2024-12-04, status=1, ipAttribution=北京)]
    2026-04-23 ms2000000030700368 来自贵州省

    审稿速度:6.0 | 投稿命中率:50.0
    经验分享:真的好慢啊,2月份投的,4月中旬提交checklist,现在还是with editor

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2316536, encodeId=3b30231653687, content=260409完成技术审查之后就一直显示with editor阶段,到260516实在是有点着急,发邮件询问进度,那边回复邮件说在安排编辑审核(对,还没安排到编辑),现在0526,还是with editor,同组同时投的一篇一区已经大修了,只能说太慢太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93f69083252, createdName=ms3000000377448113, createdTime=Tue May 26 11:00:22 CST 2026, time=2026-05-26, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2308695, encodeId=afcc23086957a, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:真的好慢啊,2月份投的,4月中旬提交checklist,现在还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30f09061934, createdName=ms2000000030700368, createdTime=Thu Apr 23 12:50:59 CST 2026, time=2026-04-23, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2252763, encodeId=bd7a2252e635a, content=1月4号投了个综述,1月17号安排编辑,现在2月17还在编辑手里没送出去外审,这也太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73df6541609, createdName=ms1000000560525324, createdTime=Thu Feb 20 10:18:32 CST 2025, time=2025-02-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2320978, encodeId=21ec23209e88b, content=这个杂志外审这么快么,邀了4个专家,有两个专家三四天就返回意见了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30f09061934, createdName=ms2000000030700368, createdTime=Wed Jun 03 14:12:06 CST 2026, time=2026-06-03, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=964224, encodeId=d19f96422486, content=偏重的研究方向: 外泌体 ; 干细胞治疗 ; Tissue regeneration <br>经验分享:刚接收了一篇,出乎意料的快和顺利,一审20天,二审30天,两个月就接收了,感觉这个杂志比较好中,前面cell stem cell,stem cell reports,stem cells和ebiomedicine都是秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Mon May 10 10:00:20 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2256903, encodeId=35b02256903a9, content=偏重的研究方向:诱导多能干细胞;干细胞<br>经验分享:3.4投稿,3.6退回修改伦理,3.7重新提交,3.10 editor assigned到现在没变,太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e93b9459971, createdName=ms7000000466366687, createdTime=Thu Mar 20 14:31:48 CST 2025, time=2025-03-20, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1230958, encodeId=01841230958cd, content=更新一下情况,Springer Nature工作人员回复了,1 他们认为杂志的流程是有问题的,就是官网说的和实际的不是一回事,需要整改 2 他们很在意这个平等问题,我们的推测是对的,这漫长审稿流程只针对老中 3 他们说,据他们调查结果,所有稿件都要数据审查,但是我表示怀疑,有些稿件不到十天就在线发表,不知道他们的审查为什么如此高速,我的伦理只有一张纸就审查了一周多,而且还是在我不断催促的情况下。4 他很感谢我提出的问题,不然这些问题不会被曝光,会监控这个杂志。我会继续反映情况,因为那个publishing editor 还要继续搞我。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efd66150329, createdName=ms3000000510280882, createdTime=Wed Jul 06 18:06:24 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2264571, encodeId=d71a22645e16d, content=偏重的研究方向:干细胞治疗<br>经验分享:1.25投稿,没多久让澄清术语,刚好过年,差点错过提交时间,后来又返回让改格式,正式投2.10,很快送外审,当时还很高兴,没多久就变成reviewer assigned,然后到三月底还没有变,发邮件催,回复让推荐审稿人,回复过去一周还是没有更新状态,于是发邮件告知要撤稿,立刻变成under review,4.27外审回来,要求10天内修回,现在又是editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bf55176474, createdName=146e9a12m86暂无昵称, createdTime=Mon May 12 02:24:18 CST 2025, time=2025-05-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2257988, encodeId=0446225e98868, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:干细胞;肝纤维化<br>经验分享:一审10天完成,给了大修,2.25返修,3.1under review至今,希望二审审稿人手下留情啊啊啊啊,我等着急用。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60252134772, createdName=fyx000, createdTime=Thu Mar 27 15:17:48 CST 2025, time=2025-03-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2240797, encodeId=75dc2240e97a4, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:肺纤维化;间充质干细胞<br>经验分享:3.19一投,4.7号checklist, 8月4号给回两个评审意见minor review, 8月13号返回,8月26显示review completed,后来又变成under review到9.23,又给了一个reviewer的意见,9.26修回。到10.22号又给了一个reviewer的minor review,10.22当天修回,11月26初步接收,补充带marker的原始图,12月3号正式接收。一共8个月15天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2919515599, createdName=ms5000000432764812, createdTime=Wed Dec 04 17:43:05 CST 2024, time=2024-12-04, status=1, ipAttribution=北京)]
    2025-02-20 ms1000000560525324 来自浙江省

    1月4号投了个综述,1月17号安排编辑,现在2月17还在编辑手里没送出去外审,这也太慢了

    6

    展开6条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2316536, encodeId=3b30231653687, content=260409完成技术审查之后就一直显示with editor阶段,到260516实在是有点着急,发邮件询问进度,那边回复邮件说在安排编辑审核(对,还没安排到编辑),现在0526,还是with editor,同组同时投的一篇一区已经大修了,只能说太慢太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93f69083252, createdName=ms3000000377448113, createdTime=Tue May 26 11:00:22 CST 2026, time=2026-05-26, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2308695, encodeId=afcc23086957a, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:真的好慢啊,2月份投的,4月中旬提交checklist,现在还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30f09061934, createdName=ms2000000030700368, createdTime=Thu Apr 23 12:50:59 CST 2026, time=2026-04-23, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2252763, encodeId=bd7a2252e635a, content=1月4号投了个综述,1月17号安排编辑,现在2月17还在编辑手里没送出去外审,这也太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73df6541609, createdName=ms1000000560525324, createdTime=Thu Feb 20 10:18:32 CST 2025, time=2025-02-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2320978, encodeId=21ec23209e88b, content=这个杂志外审这么快么,邀了4个专家,有两个专家三四天就返回意见了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30f09061934, createdName=ms2000000030700368, createdTime=Wed Jun 03 14:12:06 CST 2026, time=2026-06-03, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=964224, encodeId=d19f96422486, content=偏重的研究方向: 外泌体 ; 干细胞治疗 ; Tissue regeneration <br>经验分享:刚接收了一篇,出乎意料的快和顺利,一审20天,二审30天,两个月就接收了,感觉这个杂志比较好中,前面cell stem cell,stem cell reports,stem cells和ebiomedicine都是秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Mon May 10 10:00:20 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2256903, encodeId=35b02256903a9, content=偏重的研究方向:诱导多能干细胞;干细胞<br>经验分享:3.4投稿,3.6退回修改伦理,3.7重新提交,3.10 editor assigned到现在没变,太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e93b9459971, createdName=ms7000000466366687, createdTime=Thu Mar 20 14:31:48 CST 2025, time=2025-03-20, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1230958, encodeId=01841230958cd, content=更新一下情况,Springer Nature工作人员回复了,1 他们认为杂志的流程是有问题的,就是官网说的和实际的不是一回事,需要整改 2 他们很在意这个平等问题,我们的推测是对的,这漫长审稿流程只针对老中 3 他们说,据他们调查结果,所有稿件都要数据审查,但是我表示怀疑,有些稿件不到十天就在线发表,不知道他们的审查为什么如此高速,我的伦理只有一张纸就审查了一周多,而且还是在我不断催促的情况下。4 他很感谢我提出的问题,不然这些问题不会被曝光,会监控这个杂志。我会继续反映情况,因为那个publishing editor 还要继续搞我。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efd66150329, createdName=ms3000000510280882, createdTime=Wed Jul 06 18:06:24 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2264571, encodeId=d71a22645e16d, content=偏重的研究方向:干细胞治疗<br>经验分享:1.25投稿,没多久让澄清术语,刚好过年,差点错过提交时间,后来又返回让改格式,正式投2.10,很快送外审,当时还很高兴,没多久就变成reviewer assigned,然后到三月底还没有变,发邮件催,回复让推荐审稿人,回复过去一周还是没有更新状态,于是发邮件告知要撤稿,立刻变成under review,4.27外审回来,要求10天内修回,现在又是editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bf55176474, createdName=146e9a12m86暂无昵称, createdTime=Mon May 12 02:24:18 CST 2025, time=2025-05-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2257988, encodeId=0446225e98868, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:干细胞;肝纤维化<br>经验分享:一审10天完成,给了大修,2.25返修,3.1under review至今,希望二审审稿人手下留情啊啊啊啊,我等着急用。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60252134772, createdName=fyx000, createdTime=Thu Mar 27 15:17:48 CST 2025, time=2025-03-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2240797, encodeId=75dc2240e97a4, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:肺纤维化;间充质干细胞<br>经验分享:3.19一投,4.7号checklist, 8月4号给回两个评审意见minor review, 8月13号返回,8月26显示review completed,后来又变成under review到9.23,又给了一个reviewer的意见,9.26修回。到10.22号又给了一个reviewer的minor review,10.22当天修回,11月26初步接收,补充带marker的原始图,12月3号正式接收。一共8个月15天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2919515599, createdName=ms5000000432764812, createdTime=Wed Dec 04 17:43:05 CST 2024, time=2024-12-04, status=1, ipAttribution=北京)]
    2026-06-03 ms2000000030700368 来自贵州省

    这个杂志外审这么快么,邀了4个专家,有两个专家三四天就返回意见了

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2316536, encodeId=3b30231653687, content=260409完成技术审查之后就一直显示with editor阶段,到260516实在是有点着急,发邮件询问进度,那边回复邮件说在安排编辑审核(对,还没安排到编辑),现在0526,还是with editor,同组同时投的一篇一区已经大修了,只能说太慢太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93f69083252, createdName=ms3000000377448113, createdTime=Tue May 26 11:00:22 CST 2026, time=2026-05-26, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2308695, encodeId=afcc23086957a, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:真的好慢啊,2月份投的,4月中旬提交checklist,现在还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30f09061934, createdName=ms2000000030700368, createdTime=Thu Apr 23 12:50:59 CST 2026, time=2026-04-23, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2252763, encodeId=bd7a2252e635a, content=1月4号投了个综述,1月17号安排编辑,现在2月17还在编辑手里没送出去外审,这也太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73df6541609, createdName=ms1000000560525324, createdTime=Thu Feb 20 10:18:32 CST 2025, time=2025-02-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2320978, encodeId=21ec23209e88b, content=这个杂志外审这么快么,邀了4个专家,有两个专家三四天就返回意见了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30f09061934, createdName=ms2000000030700368, createdTime=Wed Jun 03 14:12:06 CST 2026, time=2026-06-03, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=964224, encodeId=d19f96422486, content=偏重的研究方向: 外泌体 ; 干细胞治疗 ; Tissue regeneration <br>经验分享:刚接收了一篇,出乎意料的快和顺利,一审20天,二审30天,两个月就接收了,感觉这个杂志比较好中,前面cell stem cell,stem cell reports,stem cells和ebiomedicine都是秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Mon May 10 10:00:20 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2256903, encodeId=35b02256903a9, content=偏重的研究方向:诱导多能干细胞;干细胞<br>经验分享:3.4投稿,3.6退回修改伦理,3.7重新提交,3.10 editor assigned到现在没变,太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e93b9459971, createdName=ms7000000466366687, createdTime=Thu Mar 20 14:31:48 CST 2025, time=2025-03-20, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1230958, encodeId=01841230958cd, content=更新一下情况,Springer Nature工作人员回复了,1 他们认为杂志的流程是有问题的,就是官网说的和实际的不是一回事,需要整改 2 他们很在意这个平等问题,我们的推测是对的,这漫长审稿流程只针对老中 3 他们说,据他们调查结果,所有稿件都要数据审查,但是我表示怀疑,有些稿件不到十天就在线发表,不知道他们的审查为什么如此高速,我的伦理只有一张纸就审查了一周多,而且还是在我不断催促的情况下。4 他很感谢我提出的问题,不然这些问题不会被曝光,会监控这个杂志。我会继续反映情况,因为那个publishing editor 还要继续搞我。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efd66150329, createdName=ms3000000510280882, createdTime=Wed Jul 06 18:06:24 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2264571, encodeId=d71a22645e16d, content=偏重的研究方向:干细胞治疗<br>经验分享:1.25投稿,没多久让澄清术语,刚好过年,差点错过提交时间,后来又返回让改格式,正式投2.10,很快送外审,当时还很高兴,没多久就变成reviewer assigned,然后到三月底还没有变,发邮件催,回复让推荐审稿人,回复过去一周还是没有更新状态,于是发邮件告知要撤稿,立刻变成under review,4.27外审回来,要求10天内修回,现在又是editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bf55176474, createdName=146e9a12m86暂无昵称, createdTime=Mon May 12 02:24:18 CST 2025, time=2025-05-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2257988, encodeId=0446225e98868, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:干细胞;肝纤维化<br>经验分享:一审10天完成,给了大修,2.25返修,3.1under review至今,希望二审审稿人手下留情啊啊啊啊,我等着急用。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60252134772, createdName=fyx000, createdTime=Thu Mar 27 15:17:48 CST 2025, time=2025-03-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2240797, encodeId=75dc2240e97a4, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:肺纤维化;间充质干细胞<br>经验分享:3.19一投,4.7号checklist, 8月4号给回两个评审意见minor review, 8月13号返回,8月26显示review completed,后来又变成under review到9.23,又给了一个reviewer的意见,9.26修回。到10.22号又给了一个reviewer的minor review,10.22当天修回,11月26初步接收,补充带marker的原始图,12月3号正式接收。一共8个月15天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2919515599, createdName=ms5000000432764812, createdTime=Wed Dec 04 17:43:05 CST 2024, time=2024-12-04, status=1, ipAttribution=北京)]
    2021-05-10 krygios

    偏重的研究方向: 外泌体 ; 干细胞治疗 ; Tissue regeneration
    经验分享:刚接收了一篇,出乎意料的快和顺利,一审20天,二审30天,两个月就接收了,感觉这个杂志比较好中,前面cell stem cell,stem cell reports,stem cells和ebiomedicine都是秒拒

    11

    展开11条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2316536, encodeId=3b30231653687, content=260409完成技术审查之后就一直显示with editor阶段,到260516实在是有点着急,发邮件询问进度,那边回复邮件说在安排编辑审核(对,还没安排到编辑),现在0526,还是with editor,同组同时投的一篇一区已经大修了,只能说太慢太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93f69083252, createdName=ms3000000377448113, createdTime=Tue May 26 11:00:22 CST 2026, time=2026-05-26, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2308695, encodeId=afcc23086957a, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:真的好慢啊,2月份投的,4月中旬提交checklist,现在还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30f09061934, createdName=ms2000000030700368, createdTime=Thu Apr 23 12:50:59 CST 2026, time=2026-04-23, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2252763, encodeId=bd7a2252e635a, content=1月4号投了个综述,1月17号安排编辑,现在2月17还在编辑手里没送出去外审,这也太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73df6541609, createdName=ms1000000560525324, createdTime=Thu Feb 20 10:18:32 CST 2025, time=2025-02-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2320978, encodeId=21ec23209e88b, content=这个杂志外审这么快么,邀了4个专家,有两个专家三四天就返回意见了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30f09061934, createdName=ms2000000030700368, createdTime=Wed Jun 03 14:12:06 CST 2026, time=2026-06-03, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=964224, encodeId=d19f96422486, content=偏重的研究方向: 外泌体 ; 干细胞治疗 ; Tissue regeneration <br>经验分享:刚接收了一篇,出乎意料的快和顺利,一审20天,二审30天,两个月就接收了,感觉这个杂志比较好中,前面cell stem cell,stem cell reports,stem cells和ebiomedicine都是秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Mon May 10 10:00:20 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2256903, encodeId=35b02256903a9, content=偏重的研究方向:诱导多能干细胞;干细胞<br>经验分享:3.4投稿,3.6退回修改伦理,3.7重新提交,3.10 editor assigned到现在没变,太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e93b9459971, createdName=ms7000000466366687, createdTime=Thu Mar 20 14:31:48 CST 2025, time=2025-03-20, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1230958, encodeId=01841230958cd, content=更新一下情况,Springer Nature工作人员回复了,1 他们认为杂志的流程是有问题的,就是官网说的和实际的不是一回事,需要整改 2 他们很在意这个平等问题,我们的推测是对的,这漫长审稿流程只针对老中 3 他们说,据他们调查结果,所有稿件都要数据审查,但是我表示怀疑,有些稿件不到十天就在线发表,不知道他们的审查为什么如此高速,我的伦理只有一张纸就审查了一周多,而且还是在我不断催促的情况下。4 他很感谢我提出的问题,不然这些问题不会被曝光,会监控这个杂志。我会继续反映情况,因为那个publishing editor 还要继续搞我。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efd66150329, createdName=ms3000000510280882, createdTime=Wed Jul 06 18:06:24 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2264571, encodeId=d71a22645e16d, content=偏重的研究方向:干细胞治疗<br>经验分享:1.25投稿,没多久让澄清术语,刚好过年,差点错过提交时间,后来又返回让改格式,正式投2.10,很快送外审,当时还很高兴,没多久就变成reviewer assigned,然后到三月底还没有变,发邮件催,回复让推荐审稿人,回复过去一周还是没有更新状态,于是发邮件告知要撤稿,立刻变成under review,4.27外审回来,要求10天内修回,现在又是editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bf55176474, createdName=146e9a12m86暂无昵称, createdTime=Mon May 12 02:24:18 CST 2025, time=2025-05-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2257988, encodeId=0446225e98868, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:干细胞;肝纤维化<br>经验分享:一审10天完成,给了大修,2.25返修,3.1under review至今,希望二审审稿人手下留情啊啊啊啊,我等着急用。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60252134772, createdName=fyx000, createdTime=Thu Mar 27 15:17:48 CST 2025, time=2025-03-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2240797, encodeId=75dc2240e97a4, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:肺纤维化;间充质干细胞<br>经验分享:3.19一投,4.7号checklist, 8月4号给回两个评审意见minor review, 8月13号返回,8月26显示review completed,后来又变成under review到9.23,又给了一个reviewer的意见,9.26修回。到10.22号又给了一个reviewer的minor review,10.22当天修回,11月26初步接收,补充带marker的原始图,12月3号正式接收。一共8个月15天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2919515599, createdName=ms5000000432764812, createdTime=Wed Dec 04 17:43:05 CST 2024, time=2024-12-04, status=1, ipAttribution=北京)]
    2025-03-20 ms7000000466366687 来自安徽省

    偏重的研究方向:诱导多能干细胞;干细胞
    经验分享:3.4投稿,3.6退回修改伦理,3.7重新提交,3.10 editor assigned到现在没变,太慢了

    4

    展开4条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2316536, encodeId=3b30231653687, content=260409完成技术审查之后就一直显示with editor阶段,到260516实在是有点着急,发邮件询问进度,那边回复邮件说在安排编辑审核(对,还没安排到编辑),现在0526,还是with editor,同组同时投的一篇一区已经大修了,只能说太慢太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93f69083252, createdName=ms3000000377448113, createdTime=Tue May 26 11:00:22 CST 2026, time=2026-05-26, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2308695, encodeId=afcc23086957a, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:真的好慢啊,2月份投的,4月中旬提交checklist,现在还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30f09061934, createdName=ms2000000030700368, createdTime=Thu Apr 23 12:50:59 CST 2026, time=2026-04-23, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2252763, encodeId=bd7a2252e635a, content=1月4号投了个综述,1月17号安排编辑,现在2月17还在编辑手里没送出去外审,这也太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73df6541609, createdName=ms1000000560525324, createdTime=Thu Feb 20 10:18:32 CST 2025, time=2025-02-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2320978, encodeId=21ec23209e88b, content=这个杂志外审这么快么,邀了4个专家,有两个专家三四天就返回意见了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30f09061934, createdName=ms2000000030700368, createdTime=Wed Jun 03 14:12:06 CST 2026, time=2026-06-03, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=964224, encodeId=d19f96422486, content=偏重的研究方向: 外泌体 ; 干细胞治疗 ; Tissue regeneration <br>经验分享:刚接收了一篇,出乎意料的快和顺利,一审20天,二审30天,两个月就接收了,感觉这个杂志比较好中,前面cell stem cell,stem cell reports,stem cells和ebiomedicine都是秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Mon May 10 10:00:20 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2256903, encodeId=35b02256903a9, content=偏重的研究方向:诱导多能干细胞;干细胞<br>经验分享:3.4投稿,3.6退回修改伦理,3.7重新提交,3.10 editor assigned到现在没变,太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e93b9459971, createdName=ms7000000466366687, createdTime=Thu Mar 20 14:31:48 CST 2025, time=2025-03-20, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1230958, encodeId=01841230958cd, content=更新一下情况,Springer Nature工作人员回复了,1 他们认为杂志的流程是有问题的,就是官网说的和实际的不是一回事,需要整改 2 他们很在意这个平等问题,我们的推测是对的,这漫长审稿流程只针对老中 3 他们说,据他们调查结果,所有稿件都要数据审查,但是我表示怀疑,有些稿件不到十天就在线发表,不知道他们的审查为什么如此高速,我的伦理只有一张纸就审查了一周多,而且还是在我不断催促的情况下。4 他很感谢我提出的问题,不然这些问题不会被曝光,会监控这个杂志。我会继续反映情况,因为那个publishing editor 还要继续搞我。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efd66150329, createdName=ms3000000510280882, createdTime=Wed Jul 06 18:06:24 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2264571, encodeId=d71a22645e16d, content=偏重的研究方向:干细胞治疗<br>经验分享:1.25投稿,没多久让澄清术语,刚好过年,差点错过提交时间,后来又返回让改格式,正式投2.10,很快送外审,当时还很高兴,没多久就变成reviewer assigned,然后到三月底还没有变,发邮件催,回复让推荐审稿人,回复过去一周还是没有更新状态,于是发邮件告知要撤稿,立刻变成under review,4.27外审回来,要求10天内修回,现在又是editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bf55176474, createdName=146e9a12m86暂无昵称, createdTime=Mon May 12 02:24:18 CST 2025, time=2025-05-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2257988, encodeId=0446225e98868, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:干细胞;肝纤维化<br>经验分享:一审10天完成,给了大修,2.25返修,3.1under review至今,希望二审审稿人手下留情啊啊啊啊,我等着急用。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60252134772, createdName=fyx000, createdTime=Thu Mar 27 15:17:48 CST 2025, time=2025-03-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2240797, encodeId=75dc2240e97a4, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:肺纤维化;间充质干细胞<br>经验分享:3.19一投,4.7号checklist, 8月4号给回两个评审意见minor review, 8月13号返回,8月26显示review completed,后来又变成under review到9.23,又给了一个reviewer的意见,9.26修回。到10.22号又给了一个reviewer的minor review,10.22当天修回,11月26初步接收,补充带marker的原始图,12月3号正式接收。一共8个月15天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2919515599, createdName=ms5000000432764812, createdTime=Wed Dec 04 17:43:05 CST 2024, time=2024-12-04, status=1, ipAttribution=北京)]
    2022-07-06 ms3000000510280882

    更新一下情况,Springer Nature工作人员回复了,1 他们认为杂志的流程是有问题的,就是官网说的和实际的不是一回事,需要整改 2 他们很在意这个平等问题,我们的推测是对的,这漫长审稿流程只针对老中 3 他们说,据他们调查结果,所有稿件都要数据审查,但是我表示怀疑,有些稿件不到十天就在线发表,不知道他们的审查为什么如此高速,我的伦理只有一张纸就审查了一周多,而且还是在我不断催促的情况下。4 他很感谢我提出的问题,不然这些问题不会被曝光,会监控这个杂志。我会继续反映情况,因为那个publishing editor 还要继续搞我。

    25

    展开25条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2316536, encodeId=3b30231653687, content=260409完成技术审查之后就一直显示with editor阶段,到260516实在是有点着急,发邮件询问进度,那边回复邮件说在安排编辑审核(对,还没安排到编辑),现在0526,还是with editor,同组同时投的一篇一区已经大修了,只能说太慢太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93f69083252, createdName=ms3000000377448113, createdTime=Tue May 26 11:00:22 CST 2026, time=2026-05-26, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2308695, encodeId=afcc23086957a, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:真的好慢啊,2月份投的,4月中旬提交checklist,现在还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30f09061934, createdName=ms2000000030700368, createdTime=Thu Apr 23 12:50:59 CST 2026, time=2026-04-23, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2252763, encodeId=bd7a2252e635a, content=1月4号投了个综述,1月17号安排编辑,现在2月17还在编辑手里没送出去外审,这也太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73df6541609, createdName=ms1000000560525324, createdTime=Thu Feb 20 10:18:32 CST 2025, time=2025-02-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2320978, encodeId=21ec23209e88b, content=这个杂志外审这么快么,邀了4个专家,有两个专家三四天就返回意见了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30f09061934, createdName=ms2000000030700368, createdTime=Wed Jun 03 14:12:06 CST 2026, time=2026-06-03, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=964224, encodeId=d19f96422486, content=偏重的研究方向: 外泌体 ; 干细胞治疗 ; Tissue regeneration <br>经验分享:刚接收了一篇,出乎意料的快和顺利,一审20天,二审30天,两个月就接收了,感觉这个杂志比较好中,前面cell stem cell,stem cell reports,stem cells和ebiomedicine都是秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Mon May 10 10:00:20 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2256903, encodeId=35b02256903a9, content=偏重的研究方向:诱导多能干细胞;干细胞<br>经验分享:3.4投稿,3.6退回修改伦理,3.7重新提交,3.10 editor assigned到现在没变,太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e93b9459971, createdName=ms7000000466366687, createdTime=Thu Mar 20 14:31:48 CST 2025, time=2025-03-20, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1230958, encodeId=01841230958cd, content=更新一下情况,Springer Nature工作人员回复了,1 他们认为杂志的流程是有问题的,就是官网说的和实际的不是一回事,需要整改 2 他们很在意这个平等问题,我们的推测是对的,这漫长审稿流程只针对老中 3 他们说,据他们调查结果,所有稿件都要数据审查,但是我表示怀疑,有些稿件不到十天就在线发表,不知道他们的审查为什么如此高速,我的伦理只有一张纸就审查了一周多,而且还是在我不断催促的情况下。4 他很感谢我提出的问题,不然这些问题不会被曝光,会监控这个杂志。我会继续反映情况,因为那个publishing editor 还要继续搞我。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efd66150329, createdName=ms3000000510280882, createdTime=Wed Jul 06 18:06:24 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2264571, encodeId=d71a22645e16d, content=偏重的研究方向:干细胞治疗<br>经验分享:1.25投稿,没多久让澄清术语,刚好过年,差点错过提交时间,后来又返回让改格式,正式投2.10,很快送外审,当时还很高兴,没多久就变成reviewer assigned,然后到三月底还没有变,发邮件催,回复让推荐审稿人,回复过去一周还是没有更新状态,于是发邮件告知要撤稿,立刻变成under review,4.27外审回来,要求10天内修回,现在又是editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bf55176474, createdName=146e9a12m86暂无昵称, createdTime=Mon May 12 02:24:18 CST 2025, time=2025-05-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2257988, encodeId=0446225e98868, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:干细胞;肝纤维化<br>经验分享:一审10天完成,给了大修,2.25返修,3.1under review至今,希望二审审稿人手下留情啊啊啊啊,我等着急用。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60252134772, createdName=fyx000, createdTime=Thu Mar 27 15:17:48 CST 2025, time=2025-03-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2240797, encodeId=75dc2240e97a4, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:肺纤维化;间充质干细胞<br>经验分享:3.19一投,4.7号checklist, 8月4号给回两个评审意见minor review, 8月13号返回,8月26显示review completed,后来又变成under review到9.23,又给了一个reviewer的意见,9.26修回。到10.22号又给了一个reviewer的minor review,10.22当天修回,11月26初步接收,补充带marker的原始图,12月3号正式接收。一共8个月15天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2919515599, createdName=ms5000000432764812, createdTime=Wed Dec 04 17:43:05 CST 2024, time=2024-12-04, status=1, ipAttribution=北京)]
    2025-05-12 146e9a12m86暂无昵称 来自广东省

    偏重的研究方向:干细胞治疗
    经验分享:1.25投稿,没多久让澄清术语,刚好过年,差点错过提交时间,后来又返回让改格式,正式投2.10,很快送外审,当时还很高兴,没多久就变成reviewer assigned,然后到三月底还没有变,发邮件催,回复让推荐审稿人,回复过去一周还是没有更新状态,于是发邮件告知要撤稿,立刻变成under review,4.27外审回来,要求10天内修回,现在又是editor assigned

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2316536, encodeId=3b30231653687, content=260409完成技术审查之后就一直显示with editor阶段,到260516实在是有点着急,发邮件询问进度,那边回复邮件说在安排编辑审核(对,还没安排到编辑),现在0526,还是with editor,同组同时投的一篇一区已经大修了,只能说太慢太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93f69083252, createdName=ms3000000377448113, createdTime=Tue May 26 11:00:22 CST 2026, time=2026-05-26, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2308695, encodeId=afcc23086957a, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:真的好慢啊,2月份投的,4月中旬提交checklist,现在还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30f09061934, createdName=ms2000000030700368, createdTime=Thu Apr 23 12:50:59 CST 2026, time=2026-04-23, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2252763, encodeId=bd7a2252e635a, content=1月4号投了个综述,1月17号安排编辑,现在2月17还在编辑手里没送出去外审,这也太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73df6541609, createdName=ms1000000560525324, createdTime=Thu Feb 20 10:18:32 CST 2025, time=2025-02-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2320978, encodeId=21ec23209e88b, content=这个杂志外审这么快么,邀了4个专家,有两个专家三四天就返回意见了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30f09061934, createdName=ms2000000030700368, createdTime=Wed Jun 03 14:12:06 CST 2026, time=2026-06-03, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=964224, encodeId=d19f96422486, content=偏重的研究方向: 外泌体 ; 干细胞治疗 ; Tissue regeneration <br>经验分享:刚接收了一篇,出乎意料的快和顺利,一审20天,二审30天,两个月就接收了,感觉这个杂志比较好中,前面cell stem cell,stem cell reports,stem cells和ebiomedicine都是秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Mon May 10 10:00:20 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2256903, encodeId=35b02256903a9, content=偏重的研究方向:诱导多能干细胞;干细胞<br>经验分享:3.4投稿,3.6退回修改伦理,3.7重新提交,3.10 editor assigned到现在没变,太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e93b9459971, createdName=ms7000000466366687, createdTime=Thu Mar 20 14:31:48 CST 2025, time=2025-03-20, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1230958, encodeId=01841230958cd, content=更新一下情况,Springer Nature工作人员回复了,1 他们认为杂志的流程是有问题的,就是官网说的和实际的不是一回事,需要整改 2 他们很在意这个平等问题,我们的推测是对的,这漫长审稿流程只针对老中 3 他们说,据他们调查结果,所有稿件都要数据审查,但是我表示怀疑,有些稿件不到十天就在线发表,不知道他们的审查为什么如此高速,我的伦理只有一张纸就审查了一周多,而且还是在我不断催促的情况下。4 他很感谢我提出的问题,不然这些问题不会被曝光,会监控这个杂志。我会继续反映情况,因为那个publishing editor 还要继续搞我。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efd66150329, createdName=ms3000000510280882, createdTime=Wed Jul 06 18:06:24 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2264571, encodeId=d71a22645e16d, content=偏重的研究方向:干细胞治疗<br>经验分享:1.25投稿,没多久让澄清术语,刚好过年,差点错过提交时间,后来又返回让改格式,正式投2.10,很快送外审,当时还很高兴,没多久就变成reviewer assigned,然后到三月底还没有变,发邮件催,回复让推荐审稿人,回复过去一周还是没有更新状态,于是发邮件告知要撤稿,立刻变成under review,4.27外审回来,要求10天内修回,现在又是editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bf55176474, createdName=146e9a12m86暂无昵称, createdTime=Mon May 12 02:24:18 CST 2025, time=2025-05-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2257988, encodeId=0446225e98868, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:干细胞;肝纤维化<br>经验分享:一审10天完成,给了大修,2.25返修,3.1under review至今,希望二审审稿人手下留情啊啊啊啊,我等着急用。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60252134772, createdName=fyx000, createdTime=Thu Mar 27 15:17:48 CST 2025, time=2025-03-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2240797, encodeId=75dc2240e97a4, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:肺纤维化;间充质干细胞<br>经验分享:3.19一投,4.7号checklist, 8月4号给回两个评审意见minor review, 8月13号返回,8月26显示review completed,后来又变成under review到9.23,又给了一个reviewer的意见,9.26修回。到10.22号又给了一个reviewer的minor review,10.22当天修回,11月26初步接收,补充带marker的原始图,12月3号正式接收。一共8个月15天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2919515599, createdName=ms5000000432764812, createdTime=Wed Dec 04 17:43:05 CST 2024, time=2024-12-04, status=1, ipAttribution=北京)]
    2025-03-27 fyx000 来自浙江省

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向:干细胞;肝纤维化
    经验分享:一审10天完成,给了大修,2.25返修,3.1under review至今,希望二审审稿人手下留情啊啊啊啊,我等着急用。。。

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2316536, encodeId=3b30231653687, content=260409完成技术审查之后就一直显示with editor阶段,到260516实在是有点着急,发邮件询问进度,那边回复邮件说在安排编辑审核(对,还没安排到编辑),现在0526,还是with editor,同组同时投的一篇一区已经大修了,只能说太慢太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93f69083252, createdName=ms3000000377448113, createdTime=Tue May 26 11:00:22 CST 2026, time=2026-05-26, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2308695, encodeId=afcc23086957a, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:真的好慢啊,2月份投的,4月中旬提交checklist,现在还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30f09061934, createdName=ms2000000030700368, createdTime=Thu Apr 23 12:50:59 CST 2026, time=2026-04-23, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2252763, encodeId=bd7a2252e635a, content=1月4号投了个综述,1月17号安排编辑,现在2月17还在编辑手里没送出去外审,这也太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73df6541609, createdName=ms1000000560525324, createdTime=Thu Feb 20 10:18:32 CST 2025, time=2025-02-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2320978, encodeId=21ec23209e88b, content=这个杂志外审这么快么,邀了4个专家,有两个专家三四天就返回意见了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30f09061934, createdName=ms2000000030700368, createdTime=Wed Jun 03 14:12:06 CST 2026, time=2026-06-03, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=964224, encodeId=d19f96422486, content=偏重的研究方向: 外泌体 ; 干细胞治疗 ; Tissue regeneration <br>经验分享:刚接收了一篇,出乎意料的快和顺利,一审20天,二审30天,两个月就接收了,感觉这个杂志比较好中,前面cell stem cell,stem cell reports,stem cells和ebiomedicine都是秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Mon May 10 10:00:20 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2256903, encodeId=35b02256903a9, content=偏重的研究方向:诱导多能干细胞;干细胞<br>经验分享:3.4投稿,3.6退回修改伦理,3.7重新提交,3.10 editor assigned到现在没变,太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e93b9459971, createdName=ms7000000466366687, createdTime=Thu Mar 20 14:31:48 CST 2025, time=2025-03-20, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1230958, encodeId=01841230958cd, content=更新一下情况,Springer Nature工作人员回复了,1 他们认为杂志的流程是有问题的,就是官网说的和实际的不是一回事,需要整改 2 他们很在意这个平等问题,我们的推测是对的,这漫长审稿流程只针对老中 3 他们说,据他们调查结果,所有稿件都要数据审查,但是我表示怀疑,有些稿件不到十天就在线发表,不知道他们的审查为什么如此高速,我的伦理只有一张纸就审查了一周多,而且还是在我不断催促的情况下。4 他很感谢我提出的问题,不然这些问题不会被曝光,会监控这个杂志。我会继续反映情况,因为那个publishing editor 还要继续搞我。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efd66150329, createdName=ms3000000510280882, createdTime=Wed Jul 06 18:06:24 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2264571, encodeId=d71a22645e16d, content=偏重的研究方向:干细胞治疗<br>经验分享:1.25投稿,没多久让澄清术语,刚好过年,差点错过提交时间,后来又返回让改格式,正式投2.10,很快送外审,当时还很高兴,没多久就变成reviewer assigned,然后到三月底还没有变,发邮件催,回复让推荐审稿人,回复过去一周还是没有更新状态,于是发邮件告知要撤稿,立刻变成under review,4.27外审回来,要求10天内修回,现在又是editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bf55176474, createdName=146e9a12m86暂无昵称, createdTime=Mon May 12 02:24:18 CST 2025, time=2025-05-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2257988, encodeId=0446225e98868, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:干细胞;肝纤维化<br>经验分享:一审10天完成,给了大修,2.25返修,3.1under review至今,希望二审审稿人手下留情啊啊啊啊,我等着急用。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60252134772, createdName=fyx000, createdTime=Thu Mar 27 15:17:48 CST 2025, time=2025-03-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2240797, encodeId=75dc2240e97a4, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:肺纤维化;间充质干细胞<br>经验分享:3.19一投,4.7号checklist, 8月4号给回两个评审意见minor review, 8月13号返回,8月26显示review completed,后来又变成under review到9.23,又给了一个reviewer的意见,9.26修回。到10.22号又给了一个reviewer的minor review,10.22当天修回,11月26初步接收,补充带marker的原始图,12月3号正式接收。一共8个月15天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2919515599, createdName=ms5000000432764812, createdTime=Wed Dec 04 17:43:05 CST 2024, time=2024-12-04, status=1, ipAttribution=北京)]
    2024-12-04 ms5000000432764812 来自北京

    审稿速度:12.0 | 投稿命中率:50.0
    偏重的研究方向:肺纤维化;间充质干细胞
    经验分享:3.19一投,4.7号checklist, 8月4号给回两个评审意见minor review, 8月13号返回,8月26显示review completed,后来又变成under review到9.23,又给了一个reviewer的意见,9.26修回。到10.22号又给了一个reviewer的minor review,10.22当天修回,11月26初步接收,补充带marker的原始图,12月3号正式接收。一共8个月15天

    2

    展开2条回复
共500条页码: 1/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分